RGC
Regencell Bioscience Holdings Limited
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · HK
$6.89
+6.33%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2799.63x
- Price / sales
- —
- Price / cash flow
- -743.36x
Enterprise value
- Enterprise value
- $3.4B
- EV / sales
- —
- EV / EBITDA
- -387.33x
- EV / EBIT
- -374.45x
- Market cap
- $3.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025